Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children - PubMed (original) (raw)
. 2005 Sep;116(3):e364-9.
doi: 10.1542/peds.2005-0386.
Affiliations
- PMID: 16140679
- DOI: 10.1542/peds.2005-0386
Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children
Rodrigo Escobar et al. Pediatrics. 2005 Sep.
Erratum in
- Pediatrics. 2005 Nov;116(5):1266
Abstract
Objective: To evaluate the quality of life (QOL) of untreated children with newly diagnosed attention-deficit/hyperactivity disorder (ADHD), compared with asthmatic and healthy children.
Methods: This prospective, case-control study included a group of 120 children, 6 to 12 years of age, with newly diagnosed ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Subjects were matched according to age, gender, and health care area with 2 control groups, ie, 93 asthmatic children and 120 healthy children. Sociodemographic characteristics and Child Health Questionnaire scores were collected.
Results: The QOL of children with ADHD was rated worse than that of asthmatic or healthy children for most Child Health Questionnaire domains. The greatest differences were found in behavior, social limitations attributable to physical problems, emotional impact on parents, and family activities. Almost every psychosocial domain was more affected in comparison with asthmatic children and both psychosocial and physical domains in comparison with healthy children.
Conclusions: ADHD interferes with the daily lives of children, parents, and families even more than asthma, primarily in areas related to psychosocial functioning, although evidence of impaired physical functioning also emerged. Delays in recognition, assessment, and management of ADHD may affect negatively the QOL of those children.
Similar articles
- Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF, Miller A, Fine S. Klassen AF, et al. Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087 - [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R, Hervas A, Soutullo C, Mardomingo MJ, Uruñuela A, Gilaberte I. Escobar R, et al. Actas Esp Psiquiatr. 2008 Sep-Oct;36(5):285-94. Actas Esp Psiquiatr. 2008. PMID: 18830848 Spanish. - Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P, Hsu HY, Chiou SS, Chao MC. Yang P, et al. Aust N Z J Psychiatry. 2007 Dec;41(12):998-1004. doi: 10.1080/00048670701689451. Aust N Z J Psychiatry. 2007. PMID: 17999272 - The effect of ADHD on the life of an individual, their family, and community from preschool to adult life.
Harpin VA. Harpin VA. Arch Dis Child. 2005 Feb;90 Suppl 1(Suppl 1):i2-7. doi: 10.1136/adc.2004.059006. Arch Dis Child. 2005. PMID: 15665153 Free PMC article. Review. - Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life.
Wehmeier PM, Schacht A, Barkley RA. Wehmeier PM, et al. J Adolesc Health. 2010 Mar;46(3):209-17. doi: 10.1016/j.jadohealth.2009.09.009. Epub 2010 Jan 4. J Adolesc Health. 2010. PMID: 20159496 Review.
Cited by
- Quality of Life in Caregivers of ADHD Children and Diabetes Patients.
Andrade EM, Geha LM, Duran P, Suwwan R, Machado F, do Rosário MC. Andrade EM, et al. Front Psychiatry. 2016 Jul 25;7:127. doi: 10.3389/fpsyt.2016.00127. eCollection 2016. Front Psychiatry. 2016. PMID: 27504099 Free PMC article. - Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS).
Wehmeier PM, Schacht A, Lehmann M, Dittmann RW, Silva SG, March JS. Wehmeier PM, et al. Child Adolesc Psychiatry Ment Health. 2008 May 28;2(1):11. doi: 10.1186/1753-2000-2-11. Child Adolesc Psychiatry Ment Health. 2008. PMID: 18507848 Free PMC article. - Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?
Berek M, Kordon A, Hargarter L, Mattejat F, Slawik L, Rettig K, Schäuble B. Berek M, et al. Child Adolesc Psychiatry Ment Health. 2011 Jul 26;5:26. doi: 10.1186/1753-2000-5-26. Child Adolesc Psychiatry Ment Health. 2011. PMID: 21791096 Free PMC article. - Relationship between subtypes and symptoms of ADHD, insomnia, and nightmares in connection with quality of life in children.
Grünwald J, Schlarb AA. Grünwald J, et al. Neuropsychiatr Dis Treat. 2017 Sep 5;13:2341-2350. doi: 10.2147/NDT.S118076. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28919767 Free PMC article. - Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.
Montoya A, Quail D, Anand E, Cardo E, Alda JA, Escobar R. Montoya A, et al. Atten Defic Hyperact Disord. 2014 Mar;6(1):25-34. doi: 10.1007/s12402-013-0119-5. Epub 2013 Oct 20. Atten Defic Hyperact Disord. 2014. PMID: 24142305 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical